Propranolol attenuates the malignant biological behaviors of renal cancer cells partly through modulation of the IL-6/PI3K/AKT signaling axis
Dongming Lu, Xueping Xie, Yanmei Liu, Tianyong Zhang, Haiming Fan, Shangfan Liao, Yongyang Wu · 2026
Read Propranolol attenuates the malignant biological behaviors of renal cancer cells partly through modulation of the IL-6/PI3K/AKT signaling axis by Dongming Lu, Xueping Xie, Yanmei Liu, Tianyong Zhang, Haiming Fan, Shangfan Liao, Yongyang Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13612918.txt.
Description
Dongming Lu and six co-authors test an old heart drug against kidney cancer cells in a 2026 journal article. The drug is propranolol, long used for blood pressure. The team asked whether it can slow the spread of the clear cell form of kidney cancer.
Two cancer cell lines were dosed with the drug in steps. Growth, movement, and invasion all fell, and cell death rose, as the dose climbed. The drug lifted death linked proteins and lowered proteins that help cells spread. In mice, tumors grew more slowly and ended smaller and lighter. Gene reads pointed to a signal chain with a growth factor at its head. Adding that factor back undid part of the drug's effect, which backs the chain's role.
Catalog record
| CREATOR | Dongming Lu, Xueping Xie, Yanmei Liu, Tianyong Zhang, Haiming Fan, Shangfan Liao, Yongyang Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |